Skyline Fund

Skyline Fund provides early stage and growth equity capital to Life Sciences and Technology companies throughout North America.

Skyline Fund companies:

Castle Biosciences offers proprietary molecular diagnostic assays to assist oncologists in individual risk-stratification.  Castle has two molecular diagnostic assays currently available: DecisionDx-GBM for glioblastoma multiforme, and DecisionDx-UM for uveal melanoma.
Corcept Therapeutics Inc. (NASDAQ: CORT) is a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. The Company’s lead product candidate, CORLUX, modulates the effect of cortisol — better known as the “stress hormone” — by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor. Corcept has ongoing Phase 3 studies of CORLUX in two indications – Cushing’s Syndrome and psychotic major depression.
DirectVetMarketing offers a turn-key marketing service that allows veterinarians to regain control of the prescription products aspect of the client relationship. The company provides convenient online ordering, marketing, and support to help their clients provide exceptional service to customers.
Clinical Products, LLC sells under the Extend brand name a line of delicious, convenient snacks that are clinically proven to help stabilize blood sugar for up to 9 hours. Extend Snacks are an excellent snack choice for anyone interested in blood sugar management. The company’s bars, crisps, and shakes are available in multiple flavors and can be purchased online and in leading retailers such as Target, Walgreens, Publix, and recently launched at Wal-Mart.
The DeviceFidelity suite of solutions allows mobile users to add new functionality to their mobile devices. The core innovation is the first mobile contactless method that functions with any wireless service provider. Its simple plug-and-play integration makes it easy for both financial institutions and their customers to implement.
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to creating, developing, and commercializing innovative human medicines. The Company’s first-in-class compound Linaclotide is being evaluated in a comprehensive Phase 3 clinical program for the treatment of irritable bowel syndrome with constipation and chronic constipation.
Panopto offers a flexible and easy-to-use presentation capture platform that lets users capture, edit, stream, archive, and share recordings that preserve critical knowledge. This rich media video capture software solution is available as licensed software for enterprises or individuals. It can be installed locally behind an organization’s firewall or accessed online through Panopto servers as part of a hosted service. This flexibility minimizes the technical barriers for adoption and reduces the cost of scaling the solution across an enterprise.
PharmMD offers comprehensive Medication Therapy Management (MTM) services to improve patient outcomes and lower healthcare costs by coordinating healthcare among physicians, pharmacists and patients.   The PharmMD program works with a company’s health insurance plan to confidentially review the medical, lab and prescription drug usage of all covered employees and their covered dependents. This secure, comprehensive review helps identify potentially harmful drug interactions, overuse/underuse/misuse of medications and services, and possible generic medication options.
Value Payment Systems provides electronic payment products and services to various payment industries including government and property management. The Company’s comprehensive e-payment service includes a wide array of payment channels including Internet and phone as well as emerging payment methods such as PINless debit.  The company is one of three vendors approved to handle credit card and debit card payments for the Internal Revenue Service at

Mountain Group Partners | 3835 Cleghorn Ave., Suite 300, Nashville, TN 37215 | Phone: (615) 843-9100 | Fax: (615) 313-9996
Site Map